// App-Quantinova.ai

: Health care resources utilisation and costs in patients with non-IPF progressive fibrosing interstitial lung disease

Researchers

Presenter

  • Amy Olson

Principal Investigators

  • Toby Maher

  • Margaret Salisbury

  • Valentina Acciai

  • Baher Mounir

  • Manuel Quaresma

  • Leila Zouad-Lejour

  • Christopher Wells

  • Aryeh Fischer

Medical Centers

  • National Jewish Health, Denver, CO, United States

  • Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom

  • Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan, United States

  • Boehringer Ingelheim Corporation, Ingelheim am Rhein, Germany

  • Decision Resources Grouo, Boston, United States of America

  • School of Medicine, University of Colorado, Denver, United States of America

Locations

  • United States

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Interstitial lung disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved